mYXpression is pleased to announce its participation at the Bio International Convention 2024, which will be held from June 3 to June 6 in San Diego, CA. This renowned event serves as a crucial platform for global biotechnological industry leaders to share their advancements and innovations. It presents an ideal opportunity for the France-based company to unveil its latest progress in biotechnologies.
At the heart of this prestigious event, mYXpression will showcase how its machine learning algorithm is set to revolutionize the development of innovative treatments in the fields of immunology and inflammatory diseases. Its participation underscores its ongoing commitment to the advancement of scientific research and the development of therapeutic solutions that precisely meet individual patient needs.
The representative at this event will be Georges-Igor Chagvardieff, a specialist in business development at mYXpression. He expresses his excitement about participating in the convention:
“Attending the Bio International Convention is an exceptional opportunity to highlight the significant progress we have made in the field of personalized medicine. It is in settings like this that the future of biotechnology is shaped, and we are extremely proud to actively contribute to this evolving landscape.”
The Bio International Convention 2024 promises not only to be a crossroads of opportunities but also a source of inspiration. We invite you to stay connected to follow the adventures of mYXpression at this must-attend event.
The mYXpression team is eager to share its discoveries and engage in enriching dialogues with other pioneers in the sector.
✉️ Send us a message if you would like to schedule a meeting with our Business Developer Georges-Igor Chagvardieff (info@myxpression.com) during the event to learn more about how mYXpression’s ML algorithm can solve clinical trial’s challenges for new drugs in the field of Immunogical & Inflammatory diseases.